USA Patent Issued for Barmensen's MAXODERM

Barmensen Labs is proud to announce that after years of “patent pending” status, the U.S. Patent and Trademark Office has granted Barmensen Labs its PATENT on MAXODERM’s one-of-a-kind Instant Male Enhancement Formula!

“Our formulators carefully developed MAXODERM’s unique Targeted Topical Delivery at a time when men concerned about erection quality had very few alternatives to prescription or herbal pills available,” said Tracy Meyer, Director, Business Development. “We’re excited to provide these consumers with another option – a truly effective option.”

While it seems Male Enhancement pills are on the decline as the delivery method of choice, MAXODERM’s PATENTED formula has continuously been on the rise. “It’s true. MAXODERM has helped thousands of satisfied customers and their partners and it’s so easy to use,” confirmed Ms. Meyer. “I believe MAXODERM’s success comes not only from its proprietary patented ingredient base, but also from the nature in which the formula is delivered. Male Enhancement efforts should bring a couple closer together. MAXODERM’s targeted topical delivery formula can also give your partner an opportunity to get involved in the application process itself, thereby ‘enhancing’ the overall intimate experience.”

Barmensen Labs does urge shoppers out there – Buyer Beware! Because MAXODERM is such a huge success, there will be knock-offs. Don’t be fooled by imitations. If you’re shopping for an effective, targeted solution – make sure you buy from the company that’s got the patent on the formula … Barmensen Labs!

US PATENT # 7,214,390